Latka logo
Qpex Biopharma logo

Qpex Biopharmarevenue & acquisition

San Diego, CaliforniaFounded 2018

Qpex Biopharma was acquired.

Qpex Biopharma, Inc. is a clinical-stage biopharmaceutical company committed to improving patient care across inpatient and outpatient settings, focusing on developing new antibiotics to combat the growing threat of global antimicrobial resistance.

qpexbio.comLinkedInUpdated Sep 10, 2026
Annual revenue
$7.4M
Sep 2024EST
Owner
Undisclosed
Date not on record

Qpex Biopharma revenue

Qpex Biopharma has not published its revenue. Growjo puts it at about $7.4M a year (September 2024).

$0
$2M
$4M
$6M
$0
–
$7.4M
20182019–232024
ReportedEstimateFounded 2018 at $0; every reading has its own bar
As ofRevenueSource
Sep 2024$7.4MESTGrowjo estimate

Who owns Qpex Biopharma

Another company owns Qpex Biopharma. The date and price of the deal are not on record.

Qpex Biopharma CEO

Michael Dudley was CEO of Qpex Biopharma.

Categories

How this page is sourced

1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Qpex Biopharma? Join the podcast